a.

‘Explosives’, as follows, and mixtures thereof: ADNBF (aminodinitrobenzofuroxan or 7-amino-4,6-dinitrobenzofurazane-1-oxide) (CAS 97096-78-1); BNCP (cis-bis (5-nitrotetrazolato) tetra amine-cobalt (III) perchlorate) (CAS 117412-28-9); CL-14 (diamino dinitrobenzofuroxan or 5,7-diamino-4,6-dinitrobenzofurazane-1-oxide) (CAS 117907-74-1); CL-20 (HNIW or Hexanitrohexaazaisowurtzitane) (CAS 135285-90-4); chlathrates of CL-20 (see also ML8.g.3. and g.4. for its ‘precursors’); CP (2-(5-cyanotetrazolato) penta amine-cobalt (III) Perchlorate) (CAS 70247-32-4); DADE (l,l-diamino-2,2-dinitroethylene, FOX7); DATB (diaminotrinitrobenzene) (CAS 1630-08-6); DDFP (1,4-dinitrodifurazanopiperazine); DDPO (2,6-diamino-3,5-dinitropyrazine-l-oxide, PZO) (CAS 194486-77-6); DIPAM (3,3’,-diamino-2,2’,4,4’,6,6’-hexanitrobiphenyl or dipicramide) (CAS 17215-44-0); DNGU (DINGU or dinitroglycoluril) (CAS 55510-04-8); Furazans, as follows: DAAOF (diaminoazoxyfurazan); DAAzF (diaminoazofurazan) (CAS 78644-90-3); HMX and derivatives (see also ML8.g.5. for its ‘precursors’), as follows: HMX (Cyclotetramethylenetetranitramine, octahydro-l,3.5,7-tetranitro-l,3.5,7-tetrazine, l,3.5,7-tetranitro-l,3.5,7-tetraza-cyclooctane, octogen or octogene) (CAS 2691-41-0); difluoroaminated analogs of HMX; K-55 (2.4,6,8-tetranitro-2.4,6,8-tetraazabicyclo [3.3,0]-octanone-3, tetranitrosemiglycouril or keto-bicyclic HMX) (CAS 130256-72-3); HNAD (hexanitroadamantane) (CAS 143850-71-9); HNS (hexanitrostilbene) (CAS 20062-22-0); Imidazoles, as follows: BNNII (Octahydro-2,5-bis(nitroimino)imidazo [4,5-d]imidazole); DNI (2,4-dinitroimidazole) (CAS 5213-49-0); FDIA (l-fluoro-2,4-dinitroimidazole); NTDNIA (N-(2-nitrotriazolo)-2,4-dinitroimidazole); PTIA (l-picryl-2.4,5-trinitroimidazole); NTNMH (l-(2-nitrotriazolo)-2-dinitromethylene hydrazine); ΝΤΟ (ONTA or 3-nitro-l,2,4-triazol-5-one) (CAS 932-64-9); Polynitrocubanes with more than four nitro groups; PYX (2,6-Bis(picrylamino)-3,5-dinitropyridine) (CAS 38082-89-2); RDX and derivatives, as follows: RDX (cyclotrimethylenetrinitramine, cyclonite, T4, hexahydro-l,3,5-trinitro-l,3,5-triazine, l,3,5-trinitro-l,3,5-triaza-cyclohexane, hexogen or hexogene) (CAS 121-82-4); Keto-RDX (K-6 or 2.4,6-trinitro-2.4,6-triazacyclohexanone) (CAS 115029-35-1); TAGN (triaminoguanidinenitrate) (CAS 4000-16-2); TATB (triaminotrinitrobenzene) (CAS 3058-38-6) (see also ML8.g.7 for its ‘precursors’); TEDDZ (3.3,7,7-tetrabis(difluoroamine) octahydro-l,5-dinitro-l,5-diazocine); Tetrazoles, as follows: NTAT (nitrotriazol aminotetrazole); NTNT (l-N-(2-nitrotriazolo)-4-nitrotetrazole); Tetryl (trinitrophenylmethylnitramine) (CAS 479-45-8); TNAD (l,4.5,8-tetranitro-l,4.5,8-tetraazadecalin) (CAS 135877-16-6) (see also ML8.g.6. for its ‘precursors’); TNAZ (1.3,3-trinitroazetidine) (CAS 97645-24-4) (see also ML8.g.2. for its ‘precursors’); TNGU (SORGUYL or tetranitroglycoluril) (CAS 55510-03-7); TNP (l,4.5,8-tetranitro-pyridazino[4,5-d]pyridazine) (CAS 229176-04-9); Triazines, as follows: DNAM (2-oxy-4,6-dinitroamino-s-triazine) (CAS 19899-80-0); NNHT (2-nitroimino-5-nitro-hexahydro-l,3,5-triazine) (CAS 130400-13-4); Triazoles, as follows: 5-azido-2-nitrotriazole; ADHTDN (4-amino-3,5-dihydrazino-l,2,4-triazole dinitramide) (CAS 1614-08-0); ADNT (l-amino-3,5-dinitro-l,2,4-triazole); BDNTA ([bis-dinitrotriazole]amine); DBT (3,3'-dinitro-5,5-bi-l,2,4-triazole) (CAS 30003-46-4); DNBT (dinitrobistriazole) (CAS 70890-46-9); NTDNA (2-nitrotriazole 5-dinitramide) (CAS 75393-84-9); NTDNT (1-N-(2-nitrotriazolo) 3,5-dinitrotriazole); PDNT (1-picryl-3,5-dinitrotriazole); TACOT (tetranitrobenzotriazolobenzotriazole) (CAS 25243-36-1); Any explosive not listed elsewhere in ML8.a. with a detonation velocity exceeding 8700 m/s at maximum density or a detonation pressure exceeding 34 GPa (340 kbar); Other organic explosives not listed elsewhere in ML8.a. yielding detonation pressures of 25 GPa (250 kbar) or more that will remain stable at temperatures of 523 K (250 °C) or higher for periods of five minutes or longer.

← anx_ANNEX__cpt_8__list_2 · All articles · anx_ANNEX__cpt_8__list_2__point_a__text_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-11-05 · Text as adopted (Official Journal); later amendments are not incorporated in this text.